Global Colorectal Cancer Drugs Market Outlook 2021

Publisher Name :
Date: 23-Nov-2020
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment , the Colorectal Cancer Drugs market is segmented into

- Vascular Endothelial Growth Factor (VEGF) Inhibitors

- Epidermal Growth Factor Receptor (EGFR) Inhibitors

- Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

- BRAF or MEK Inhibitors

- Tyrosine Kinase (TKI) Inhibitors

- Immunomodulators

Segment

- Radiotherapy

- Chemotherapy

Global Colorectal Cancer Drugs Market: Regional Analysis

The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast and segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Colorectal Cancer Drugs market report are:

- North America

- United States

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Colorectal Cancer Drugs Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Colorectal Cancer Drugs market include:

- AB Science

- Amgen

- Array BioPharma

- Bayer

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Elli Lilly

- Roch

- Hutchison MediPharma

- Merck & Co., Inc.

- Mologen

- Regeneron

- Sanofi

- Sumitomo Dainippon

- Taiho Pharmaceutical

- Vaccinogen

Global Colorectal Cancer Drugs Market Outlook 2021

Table of Contents
1 Colorectal Cancer Drugs Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Drugs
1.2 Colorectal Cancer Drugs Segment
1.2.1 Global Colorectal Cancer Drugs Sales Growth Rate Comparison (2021-2026)
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Colorectal Cancer Drugs Segment
1.3.1 Colorectal Cancer Drugs Sales Comparison : 2020 VS 2026
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Colorectal Cancer Drugs Revenue 2015-2026
1.4.2 Global Colorectal Cancer Drugs Sales 2015-2026
1.4.3 Colorectal Cancer Drugs Market Size by Region: 2020 Versus 2026
1.5 Colorectal Cancer Drugs Industry
1.6 Colorectal Cancer Drugs Market Trends
2 Global Colorectal Cancer Drugs Market Competition by Manufacturers
2.1 Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Colorectal Cancer Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Colorectal Cancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Colorectal Cancer Drugs Market Competitive Situation and Trends
2.5.1 Colorectal Cancer Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)
3 Colorectal Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Colorectal Cancer Drugs Market Facts & Figures by Country
3.3.1 North America Colorectal Cancer Drugs Sales by Country
3.3.2 North America Colorectal Cancer Drugs Sales by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Colorectal Cancer Drugs Market Facts & Figures by Country
3.4.1 Europe Colorectal Cancer Drugs Sales by Country
3.4.2 Europe Colorectal Cancer Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Colorectal Cancer Drugs Sales by Region
3.5.2 Asia Pacific Colorectal Cancer Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Colorectal Cancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Colorectal Cancer Drugs Sales by Country
3.6.2 Latin America Colorectal Cancer Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country
3.7.2 Middle East and Africa Colorectal Cancer Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Colorectal Cancer Drugs Historic Market Analysis
4.1 Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
4.2 Global Colorectal Cancer Drugs Revenue Market Share (2015-2020)
4.3 Global Colorectal Cancer Drugs Price Market Share (2015-2020)
4.4 Global Colorectal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Colorectal Cancer Drugs Historic Market Analysis
5.1 Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
5.2 Global Colorectal Cancer Drugs Revenue Market Share (2015-2020)
5.3 Global Colorectal Cancer Drugs Price (2015-2020)
6 Company Profiles and Key Figures in Colorectal Cancer Drugs Business
6.1 AB Science
6.1.1 Corporation Information
6.1.2 AB Science Description, Business Overview and Total Revenue
6.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AB Science Products Offered
6.1.5 AB Science Recent Development
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description, Business Overview and Total Revenue
6.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Amgen Products Offered
6.2.5 Amgen Recent Development
6.3 Array BioPharma
6.3.1 Array BioPharma Corporation Information
6.3.2 Array BioPharma Description, Business Overview and Total Revenue
6.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Array BioPharma Products Offered
6.3.5 Array BioPharma Recent Development
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description, Business Overview and Total Revenue
6.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bayer Products Offered
6.4.5 Bayer Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bristol-Myers Squibb Products Offered
6.6.5 Bristol-Myers Squibb Recent Development
6.7 Elli Lilly
6.6.1 Elli Lilly Corporation Information
6.6.2 Elli Lilly Description, Business Overview and Total Revenue
6.6.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Elli Lilly Products Offered
6.7.5 Elli Lilly Recent Development
6.8 Roch
6.8.1 Roch Corporation Information
6.8.2 Roch Description, Business Overview and Total Revenue
6.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Roch Products Offered
6.8.5 Roch Recent Development
6.9 Hutchison MediPharma
6.9.1 Hutchison MediPharma Corporation Information
6.9.2 Hutchison MediPharma Description, Business Overview and Total Revenue
6.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hutchison MediPharma Products Offered
6.9.5 Hutchison MediPharma Recent Development
6.10 Merck & Co., Inc.
6.10.1 Merck & Co., Inc. Corporation Information
6.10.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
6.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Merck & Co., Inc. Products Offered
6.10.5 Merck & Co., Inc. Recent Development
6.11 Mologen
6.11.1 Mologen Corporation Information
6.11.2 Mologen Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Mologen Products Offered
6.11.5 Mologen Recent Development
6.12 Regeneron
6.12.1 Regeneron Corporation Information
6.12.2 Regeneron Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Regeneron Products Offered
6.12.5 Regeneron Recent Development
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Sanofi Products Offered
6.13.5 Sanofi Recent Development
6.14 Sumitomo Dainippon
6.14.1 Sumitomo Dainippon Corporation Information
6.14.2 Sumitomo Dainippon Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Sumitomo Dainippon Products Offered
6.14.5 Sumitomo Dainippon Recent Development
6.15 Taiho Pharmaceutical
6.15.1 Taiho Pharmaceutical Corporation Information
6.15.2 Taiho Pharmaceutical Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Taiho Pharmaceutical Products Offered
6.15.5 Taiho Pharmaceutical Recent Development
6.16 Vaccinogen
6.16.1 Vaccinogen Corporation Information
6.16.2 Vaccinogen Colorectal Cancer Drugs Description, Business Overview and Total Revenue
6.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Vaccinogen Products Offered
6.16.5 Vaccinogen Recent Development
7 Colorectal Cancer Drugs Manufacturing Cost Analysis
7.1 Colorectal Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Colorectal Cancer Drugs
7.4 Colorectal Cancer Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Colorectal Cancer Drugs Distributors List
8.3 Colorectal Cancer Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Colorectal Cancer Drugs Market Estimates and Projections
10.1.1 Global Forecasted Sales of Colorectal Cancer Drugs (2021-2026)
10.1.2 Global Forecasted Revenue of Colorectal Cancer Drugs (2021-2026)
10.2 Colorectal Cancer Drugs Market Estimates and Projections
10.2.1 Global Forecasted Sales of Colorectal Cancer Drugs (2021-2026)
10.2.2 Global Forecasted Revenue of Colorectal Cancer Drugs (2021-2026)
10.3 Colorectal Cancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Colorectal Cancer Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Colorectal Cancer Drugs by Region (2021-2026)
10.4 North America Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.5 Europe Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.7 Latin America Colorectal Cancer Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Colorectal Cancer Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Colorectal Cancer Drugs Sales (MT) Growth Rate Comparison (2015-2026)
Table 2. Global Colorectal Cancer Drugs Sales (MT) Comparison : 2020 VS 2026
Table 3. Global Colorectal Cancer Drugs Market Size (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Colorectal Cancer Drugs Manufacturers Covered in This Study
Table 5. Global Colorectal Cancer Drugs Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Colorectal Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Colorectal Cancer Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Colorectal Cancer Drugs Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Colorectal Cancer Drugs Sales Sites and Area Served
Table 11. Manufacturers Colorectal Cancer Drugs Product Types
Table 12. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Colorectal Cancer Drugs Players
Table 16. Global Colorectal Cancer Drugs Sales (MT) by Region (2015-2020)
Table 17. Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Colorectal Cancer Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 21. North America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 25. Europe Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Colorectal Cancer Drugs Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 33. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Colorectal Cancer Drugs Sales (MT) (2015-2020)
Table 41. Global Colorectal Cancer Drugs Sales Share (2015-2020)
Table 42. Global Colorectal Cancer Drugs Revenue (Million US$) (2015-2020)
Table 43. Global Colorectal Cancer Drugs Revenue Share (2015-2020)
Table 44. Global Colorectal Cancer Drugs Price (USD/Kg) (2015-2020)
Table 45. Global Colorectal Cancer Drugs Sales (MT) (2015-2020)
Table 46. Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
Table 47. Global Colorectal Cancer Drugs Sales Growth Rate (2015-2020)
Table 48. AB Science Colorectal Cancer Drugs Corporation Information
Table 49. AB Science Description and Business Overview
Table 50. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. AB Science Main Product
Table 52. AB Science Recent Development
Table 53. Amgen Colorectal Cancer Drugs Corporation Information
Table 54. Amgen Corporation Information
Table 55. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Amgen Main Product
Table 57. Amgen Recent Development
Table 58. Array BioPharma Colorectal Cancer Drugs Corporation Information
Table 59. Array BioPharma Corporation Information
Table 60. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Array BioPharma Main Product
Table 62. Array BioPharma Recent Development
Table 63. Bayer Colorectal Cancer Drugs Corporation Information
Table 64. Bayer Corporation Information
Table 65. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Bayer Main Product
Table 67. Bayer Recent Development
Table 68. Boehringer Ingelheim Colorectal Cancer Drugs Corporation Information
Table 69. Boehringer Ingelheim Corporation Information
Table 70. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Boehringer Ingelheim Main Product
Table 72. Boehringer Ingelheim Recent Development
Table 73. Bristol-Myers Squibb Colorectal Cancer Drugs Corporation Information
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Bristol-Myers Squibb Main Product
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Elli Lilly Colorectal Cancer Drugs Corporation Information
Table 79. Elli Lilly Corporation Information
Table 80. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Elli Lilly Main Product
Table 82. Elli Lilly Recent Development
Table 83. Roch Colorectal Cancer Drugs Corporation Information
Table 84. Roch Corporation Information
Table 85. Roch Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Roch Main Product
Table 87. Roch Recent Development
Table 88. Hutchison MediPharma Colorectal Cancer Drugs Corporation Information
Table 89. Hutchison MediPharma Corporation Information
Table 90. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Hutchison MediPharma Main Product
Table 92. Hutchison MediPharma Recent Development
Table 93. Merck & Co., Inc. Colorectal Cancer Drugs Corporation Information
Table 94. Merck & Co., Inc. Corporation Information
Table 95. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Merck & Co., Inc. Main Product
Table 97. Merck & Co., Inc. Recent Development
Table 98. Mologen Colorectal Cancer Drugs Corporation Information
Table 99. Mologen Corporation Information
Table 100. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Mologen Main Product
Table 102. Mologen Recent Development
Table 103. Regeneron Colorectal Cancer Drugs Corporation Information
Table 104. Regeneron Corporation Information
Table 105. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Regeneron Main Product
Table 107. Regeneron Recent Development
Table 108. Sanofi Colorectal Cancer Drugs Corporation Information
Table 109. Sanofi Corporation Information
Table 110. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Sanofi Main Product
Table 112. Sanofi Recent Development
Table 113. Sumitomo Dainippon Colorectal Cancer Drugs Corporation Information
Table 114. Sumitomo Dainippon Corporation Information
Table 115. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Sumitomo Dainippon Main Product
Table 117. Sumitomo Dainippon Recent Development
Table 118. Taiho Pharmaceutical Colorectal Cancer Drugs Corporation Information
Table 119. Taiho Pharmaceutical Corporation Information
Table 120. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Taiho Pharmaceutical Main Product
Table 122. Taiho Pharmaceutical Recent Development
Table 123. Vaccinogen Colorectal Cancer Drugs Corporation Information
Table 124. Vaccinogen Corporation Information
Table 125. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Vaccinogen Main Product
Table 127. Vaccinogen Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Colorectal Cancer Drugs Distributors List
Table 131. Colorectal Cancer Drugs Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Colorectal Cancer Drugs Sales (MT) Forecast (2021-2026)
Table 136. Global Colorectal Cancer Drugs Sales Market Share Forecast (2021-2026)
Table 137. Global Colorectal Cancer Drugs Revenue (Million US$) Forecast (2021-2026)
Table 138. Global Colorectal Cancer Drugs Revenue (Million US$) Market Share Forecast (2021-2026)
Table 139. Global Colorectal Cancer Drugs Sales (MT) Forecast (2021-2026)
Table 140. Global Colorectal Cancer Drugs Revenue (Million US$) Forecast (2021-2026)
Table 141. Global Colorectal Cancer Drugs Sales (MT) Forecast by Region (2021-2026)
Table 142. Global Colorectal Cancer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Colorectal Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Colorectal Cancer Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Colorectal Cancer Drugs
Figure 2. Global Colorectal Cancer Drugs Sales Market Share : 2020 VS 2026
Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
Figure 6. BRAF or MEK Inhibitors Product Picture
Figure 7. Tyrosine Kinase (TKI) Inhibitors Product Picture
Figure 8. Immunomodulators Product Picture
Figure 9. Global Colorectal Cancer Drugs Consumption Market Share : 2020 VS 2026
Figure 10. Radiotherapy
Figure 11. Chemotherapy
Figure 12. Global Colorectal Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Colorectal Cancer Drugs Sales Capacity (MT) (2015-2026)
Figure 14. Global Colorectal Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Colorectal Cancer Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Colorectal Cancer Drugs Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Colorectal Cancer Drugs Revenue in 2019
Figure 18. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 21. Global Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 23. North America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 24. North America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 25. United States Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 26. United States Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 28. Canada Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 30. Europe Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 31. Germany Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 32. Germany Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 34. France Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 36. U.K. Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 38. Italy Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 40. Russia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 42. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 43. China Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 44. China Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 46. Japan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 48. South Korea Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 50. India Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 52. Australia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 54. Taiwan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 56. Indonesia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 58. Thailand Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 60. Malaysia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 62. Philippines Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 64. Vietnam Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 66. Latin America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 67. Mexico Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 68. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 70. Brazil Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 72. Argentina Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 75. Turkey Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 76. Turkey Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 78. Saudi Arabia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 80. U.A.E Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Colorectal Cancer Drugs (2015-2020)
Figure 82. Sales Market Share of Colorectal Cancer Drugs in 2019
Figure 83. Revenue Share of Colorectal Cancer Drugs (2015-2020)
Figure 84. Revenue Market Share of Colorectal Cancer Drugs in 2019
Figure 85. Global Colorectal Cancer Drugs Sales Growth (2015-2020) (MT)
Figure 86. Global Colorectal Cancer Drugs Sales Market Share (2015-2020)
Figure 87. Global Colorectal Cancer Drugs Sales Market Share in 2019
Figure 88. Global Revenue Share of Colorectal Cancer Drugs (2015-2020)
Figure 89. Global Revenue Share of Colorectal Cancer Drugs in 2020
Figure 90. AB Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Elli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Roch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Hutchison MediPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Mologen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Sumitomo Dainippon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Taiho Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Vaccinogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Colorectal Cancer Drugs
Figure 108. Manufacturing Process Analysis of Colorectal Cancer Drugs
Figure 109. Colorectal Cancer Drugs Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Colorectal Cancer Drugs Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. North America Colorectal Cancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Colorectal Cancer Drugs Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Colorectal Cancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Colorectal Cancer Drugs Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Colorectal Cancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Colorectal Cancer Drugs Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Colorectal Cancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Colorectal Cancer Drugs Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Colorectal Cancer Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
  • Global Cancer Treatment Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 133
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Targeted Therapy - Immunotherapy - Hormonal Therapy (Biologic Therapy) - Other......
  • Global DNA Repair Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - PARP Inhibitors - Other Segment by Application - Oncological - Stroke ......
  • Global Docetaxel Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 20 mg/ml - 40 mg/ml - 60 mg/ml Segment by Application - Breast Cancer - Prosta......
  • Global Multiple Myeloma Drugs Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Corticosteroids - Immunomodulators - Monoclonal Antibodies - Histone Deacetyla......
  • Global Capecitabine Market Research Report 2021
    Published: 13-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 500 mg - 150 mg Segment by Application - Breast Cancer - Colorectal Cancer - S......
  • Global Xeloda Market Research Report 2021
    Published: 12-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 500 mg - 150 mg Segment by Application - Breast Cancer - Colorectal cancer - S......
  • Global Colorectal Cancer Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 05-Jan-2021        Price: US 3500 Onwards        Pages: 126
    Colorectal Cancer Drugs are drugs for the treatment of colorectal cancer. Based on the Colorectal Cancer Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics......
  • Global Erbitux Market Research Report 2021
    Published: 05-Jan-2021        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Pill Segment by Application - Pregnant woman - Children - Aged ......
  • Global 5-fluorouracil Market Research Report 2021
    Published: 04-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Injectables - Capsules - Tablets Segment by Application - Colon and Rectal Cancer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs